Ingredients
Maltodextrin (non-GMO source), vegetarian capsule (hydroxypropylmethylcellulose, titanium dioxide), cellulose and magnesium stearate (vegetable source).
Supplement Facts
Supplement Facts | ||
Serving Size: 1 Capsule | ||
Amount Per Serving: | % DV | |
Proprietary Probiotic Blend Lacticaseibacillus rhamnosus, GR-1®† Limosilactobacillus reuteri, RC-14® † | 134 mg (5 Billion CFU§) | †† †† †† |
††Daily Value (DV) not established. † Under License from Chr. Hansen A/S and protected by Chr. Hansen patents of the WO 00/35465 patented family, and others. §Minimum 5 billion viable cells at time of consumption, under recommended storage conditions and within Best Used Before date. |
Warnings
Keep refrigerated.
Keep out of the reach of children.
Consult a healthcare professional before using this product if you are trying to conceive, pregnant, or lactating, under the age of 18, or have a medical condition; if adverse reactions occur, discontinue use.
Dimensions
dimensions: 4.6 x 2.3 x 2.3 indimensionsIn: 4.6 x 2.3 x 2.3 in
dimensionsCm: 11.7 x 5.8 x 5.8 cm
Weight
weight: 0.17 lbweightLb: 0.17 lb
weightKg: 0.08 kg
- Vaginal/Urinary Tract Health
- 25+ Years of Research/Clinical Studies**
- Patented Strains
- L. Rhamnosus GR-1® &; L. Reuteri RC-14®
- Oral Probiotic Supplement
- Gluten Free
- Vegan
- Strains Matter
- Free of Major Allergens
- Suitable for Vegetarians/Vegans
- Jarrow Formulas' Probiotics Contain Clinically Documented Strains
GR-1®/RC-14® and Vaginal FLORA (also called microbiota)
In one of the randomized clinical trials, 75% of women in the GR-1®/RC-14® probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.
Fem-Dophilus® contains two patented and clinically documented probiotic strains, Lacticaseibacillus rhamnosus GR-1®‡ and Limosilactobacillus reuteri RC-14®‡, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1® and RC-14® to colonize and promote healthy vaginal and urinary tract health. A special manufacturing process protects the probiotic strains in Fem-Dophilus® from stomach acid and enhances probiotic bacterial survival to the lower intestine.
‡Updates based on official taxonomy reclassification.
**25+ Years of GR-1®/RC-14® research/clinical studies.